Memorial Sloan Kettering West Harrison

Harrison, New York 10604

0 studies enrolling now · 27 studies all time

What they study most

Adenocarcinoma, Basal Cell Carcinoma, Bladder Cancer, Brain Cancer, Breast Cancer, Cancer Patients First-ever Acute Ischemic Stroke, Clinical Masaoka Stage II to IVA, Colorectal Metastases to the Lung, Epithelial Ovarian Cancer, Esophageal Adenocarcinoma, Fallopian Tube Cancer, Head and Neck Cancer

Studies at this site

• Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma — Running, not enrolling
• Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma — Running, not enrolling
• Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer — Completed
• Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib — Running, not enrolling
• Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer — Completed
• Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma — Completed
• A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide — Completed
• Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant — Completed
• Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material — Completed
• Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas — Completed
• Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification — Completed
• 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy — Completed
• Enoxaparin Versus Aspirin in Patients With Cancer and Stroke — Completed
• Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer — Completed
• Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics — Completed
• Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer Margins — Completed
• Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation — Completed
• Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer — Completed
• Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma — Completed
• Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps — Completed
• Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer — Completed
• Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L — Completed
• Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib — Completed
• Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life — Completed
• Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. — Completed
• Irreversible Electroporation Ablation for Colorectal Metastases to the Lung — Completed
• Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL) — Completed